Projects

This project aims to strengthen surveillance of zoonotic malaria in Indonesia, including evaluating the disease burden, agricultural practices, and mosquito vectors and monkey hosts associated with the transmission, in order to inform public health control efforts and sustainable agricultural development.

This project aims to strengthen surveillance of zoonotic malaria in Indonesia, including evaluating the disease burden, agricultural practices, and mosquito vectors and monkey hosts associated with the transmission, in order to inform public health control efforts and sustainable agricultural development.

This project aims to determine whether prone positioning of hospitalized Vietnamese patients with moderate to severe COVID-19 for ≥ 8 hours a day reduces the need for escalation of respiratory therapy compared to standard care.

This study will evaluate a range of novel tests that hold promise to function at different levels of health care. We will evaluate the performance of these tests according to internationally established target product profiles (TPP).

The study aims to explore antimicrobial use (AMU) in hospitalised patients and identify targets for quality improvement of antimicrobial prescribing, adopting a mixed-method design of quantitative (observed use) and qualitative (reported experiences) measures.

This study recruits a cohort of university students undertaking their studies in Ho Chi Minh City to explore their perceptions and views of clinical and public health-orientated research focused on dengue and to examine factors that influence these views.

This project aimed to understand the perceptions and willingness of these groups to engage with antimicrobial stewardship programs in hospitals (AMS).

This project aims to provide rich contextual information to inform the design and implementation of tools that can bring high-quality critical care to low-resource settings.

This project aims to improve AMR control in Vietnam by extending AMS to underserved clinical activities in Vietnam, i.e. outpatient departments and district hospitals.

This study is a randomised, open label, controlled adaptive platform trial that will be conducted in low-risk patients with COVID-19, recruited from outpatient COVID-19/ Acute Respiratory Infection (ARI) clinics or through other approved facilities. Previously healthy patients 18 to 60 years old with early symptomatic COVID-19 and without co-morbidities are eligible for the study. Enrolled patients are followed up daily for 7 days and then on Day 10 and Day 14. Phone follow-up is conducted on Day 28 and Day 120. The interventions in this study currently includes Nitazoxanide, Paxlovid (Nirmatrelvir/Ritonavir), Metformin and Atelotrelvir/Ritonavir.